In breast cancer month October, Stratipath co-founder Johan Hartman appeared as an expert guest on Swedish TV4âs morning news, alongside Susanne Dieroff Hay, Chair of Bröstcancerförbundet (the Swedish Breast Cancer Association). The discussion focused on the latest breast cancer report and the pressing issue of unequal access to precision diagnostics across the country.
Report: New Drugs Are Not Reaching All Breast Cancer Patients, 7 min 41 sec
Advances in breast cancer research are providing entirely new opportunities to diagnose and treat the most common cancer among women. Today, the Breast Cancer Association is releasing a report on access to the advanced diagnostic methods needed to determine whether a patient will benefit from specific medications, known as precision diagnostics. Susanne Dieroff Hay, Chair of the Breast Cancer Association, and Johan Hartman, tumor pathologist at Karolinska University Hospital, share their insights.
